Paige is at the forefront of transforming cancer diagnosis through its advanced diagnostic AI technologies, specifically designed for pathology. The Paige Platform facilitates the complete digitization of pathology laboratories, enhancing the capabilities of healthcare professionals beyond traditional methods. This innovative platform is built on extensive datasets, enabling AI-driven precision in cancer detection and diagnosis. The company offers a robust portfolio of AI applications, including the Paige Breast Suite and Paige Prostate Suite, which support pathologists in identifying and diagnosing various cancers. These applications are clinically validated and have demonstrated significant improvements in diagnostic accuracy and efficiency, including reductions in cancer detection errors and time to diagnosis.

In addition to its core diagnostic tools, Paige emphasizes the importance of interoperability and AI integration within its products, positioning itself as a comprehensive solution for modern pathology needs. The company’s commitment to advancing digital pathology is further underscored by its strategic partnerships and the introduction of groundbreaking AI models, such as Virchow and PRISM. These initiatives aim to revolutionize cancer research, diagnostics, and drug development, ultimately contributing to improved patient outcomes. By leveraging cutting-edge technology, Paige is dedicated to empowering healthcare professionals and enhancing the overall standard of care in oncology.

United States

Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists' workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options. 

Learn more about Paige: https://www.paige.ai

Paige

Company Details